Loading organizations...
Key people at LifeCare Partners.
LifeCare Hospitals operates a network of specialized acute care facilities focused on critical care. The company provides early intervention and patient-centered treatment for medically complex individuals, addressing conditions such as pulmonary and ventilator weaning, neuro/post trauma, cardiac issues, infectious diseases, and wound care. Their approach integrates a team-based methodology to optimize recovery and outcomes for patients requiring extended acute care.
The organization was founded in 1992 with Phillip B. Douglas serving as a key founding figure, including roles as CEO and Chairman of LifeCare Holdings. Douglas’s vision was to establish dedicated acute care hospitals that could manage patients with intricate medical needs more effectively than traditional settings, emphasizing early mobilization and comprehensive care management from inception.
LifeCare Hospitals primarily serves medically complex patients who benefit from long-term acute care, working in close partnership with referring healthcare professionals. The company's overarching mission is to redefine critical care delivery, striving to facilitate quicker and more effective recovery paths for patients. They aim to advance patient care management through their specialized acute hospital model.
Key people at LifeCare Partners.
LifeCare Partners has 4 tracked investments across 3 companies. The latest tracked deal is $11.5M Series A Extension in Kupando in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | Kupando | $11.5M Series A Extension | Lifecare Partners, Kazuhiko Nonomura | Brandenburg Kapital, Martin Raditsch, Phd, Rttp, High Tech Grunderfonds, Ventura BioMed Investors |
| Sep 26, 2022 | Kupando | $1.3B Series A | Lifecare Partners, Remiges Ventures | Brandenburg Kapital, High Tech Grunderfonds, Ventura BioMed Investors |
| Mar 18, 2021 | NeoPrediX | $4.4M Series A | Lifecare Partners | Bayern Kapital, Eckenstein Geigy Stiftung |
| Sep 28, 2016 | Immunic Therapeutics | $19.6M Series A | Lifecare Partners, Jörg Neermann | Bayern Kapital, High Tech Grunderfonds |